Literature DB >> 17854009

Arguing for the motion: yes, RAGE is a receptor for advanced glycation endproducts.

Ravichandran Ramasamy1, Shi Fang Yan, Ann Marie Schmidt.   

Abstract

Advanced glycation endproducts (AGEs) are an heterogenous class of compounds formed by diverse stimuli, including hyperglycemia, oxidative stress, inflammation, renal failure, and innate aging. Recent evidence suggests that dietary sources of AGE may contribute to pathology. AGEs impart diverse effects in cells; evidence strongly suggests that crosslinking of proteins by AGEs may irrevocably alter basement membrane integrity and function. In addition, the ability of AGEs to bind to cells and activate signal transduction, thereby affecting broad properties in the cellular milieu, indicates that AGEs are not innocent bystanders in the diseases of AGEing. Here, we present evidence that receptor for AGE (RAGE) is a receptor for AGEs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17854009     DOI: 10.1002/mnfr.200700008

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  22 in total

1.  Advanced glycation endproducts regulate smooth muscle cells calcification in cultured HSMCs.

Authors:  Hu-Qiang He; Yong Liu; Hong Zeng; Xiao-Lei Sun; Lei Zhang; Xue-Lin Zhang; Wen-Jun Liao; Xiang-Yu Zhou; Yan-Zheng He
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 2.  Ameliorative effects of taurine against diabetes: a review.

Authors:  Fengyuan Piao; Rana Muhammad Aadil; Raheel Suleman; Kaixin Li; Mengren Zhang; Pingan Wu; Muhammad Shahbaz; Zulfiqar Ahmed
Journal:  Amino Acids       Date:  2018-02-28       Impact factor: 3.520

Review 3.  Mechanisms of disease: the oxidative stress theory of diabetic neuropathy.

Authors:  Claudia Figueroa-Romero; Mahdieh Sadidi; Eva L Feldman
Journal:  Rev Endocr Metab Disord       Date:  2008-12       Impact factor: 6.514

Review 4.  Diabetic neuropathy: mechanisms to management.

Authors:  James L Edwards; Andrea M Vincent; Hsinlin T Cheng; Eva L Feldman
Journal:  Pharmacol Ther       Date:  2008-06-13       Impact factor: 12.310

5.  Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE).

Authors:  H Zong; M Ward; A Madden; P H Yong; G A Limb; T M Curtis; A W Stitt
Journal:  Diabetologia       Date:  2010-09-12       Impact factor: 10.122

6.  The Role of receptor for Advanced Glycation End Products (RAGE) in the proliferation of hepatocellular carcinoma.

Authors:  Al-Madhagi Yaser; Yan Huang; Rong-Rong Zhou; Guan-Sheng Hu; Mei-Fang Xiao; Zhe-Bing Huang; Chao-Jun Duan; Wei Tian; Dao-Lin Tang; Xue-Gong Fan
Journal:  Int J Mol Sci       Date:  2012-05-18       Impact factor: 6.208

Review 7.  RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation.

Authors:  Louis J Sparvero; Denise Asafu-Adjei; Rui Kang; Daolin Tang; Neilay Amin; Jaehyun Im; Ronnye Rutledge; Brenda Lin; Andrew A Amoscato; Herbert J Zeh; Michael T Lotze
Journal:  J Transl Med       Date:  2009-03-17       Impact factor: 5.531

8.  Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands.

Authors:  Dachun Yao; Michael Brownlee
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

9.  Activation of Akt by advanced glycation end products (AGEs): involvement of IGF-1 receptor and caveolin-1.

Authors:  Su-Jung Yang; Chen-Yu Chen; Geen-Dong Chang; Hui-Chin Wen; Ching-Yu Chen; Shi-Chuan Chang; Jyh-Fei Liao; Chung-Ho Chang
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

10.  Specific siRNA targeting receptor for advanced glycation end products (RAGE) decreases proliferation in human breast cancer cell lines.

Authors:  Al-Madhagi Radia; Al-Madhagi Yaser; Xiaoqian Ma; Juan Zhang; Cejun Yang; Qiong Dong; Pengfei Rong; Bin Ye; Sheng Liu; Wei Wang
Journal:  Int J Mol Sci       Date:  2013-04-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.